SHERRY RAY: Open Payments
NPI 1548341175 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 54 payments from 18 companies in 2025. Trend: 2023 $750 · 2024 $887 · 2025 $918
Food & beverage: $918
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $195 |
| ABBVIE INC. | 12 | $178 |
| Novo Nordisk Inc | 7 | $137 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $30 |
| Linvatec Corporation | 1 | $27 |
Products named: VRAYLAR, NURTEC ODT, Wegovy, PREVNAR 20, XIFAXAN, Kerendia, VYEPTI, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
